Skip to content

Evaluation of the Prebiotic Potential of Yacon (Smallanthus sonchifolius) in Humans

Evaluation of the Prebiotic Potential of Yacon (Smallanthus sonchifolius) in Humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001358
Enrollment
Unknown
Registered
2025-07-09
Start date
2024-10-20
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Yacon intervention group:Yacon

Sponsors

Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Male and female participants aged 18 to 60 years; body mass index (BMI) > 18.5 kg/m²; no major chronic diseases; no use of antidiabetic lipid-lowering or anti-inflammatory drugs within the past 30 days; not enrolled in any other clinical trials; voluntarily agreed to participate and signed written informed consent.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had used antibiotics probiotics or other medications affecting gut microbiota within the past 30 days; had a history of gastrointestinal diseases such as inflammatory bowel disease or irritable bowel syndrome; had allergies to yacon or related foods; were pregnant or breastfeeding; had psychiatric or neurological disorders; or had a daily alcohol intake greater than 30 g for men or 15 g for women.

Design outcomes

Primary

MeasureTime frame
gut microbiota analysis;fecal non-targeted metabolomics analysis;

Secondary

MeasureTime frame
Constipation symptom score;Gastrointestinal symptom score;

Countries

China

Contacts

Public ContactHe Zhu

Taizhou People's Hospital

Kkaapss@163.com+86 18384241692

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026